Sacral Nerve Stimulator Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global sacral nerve stimulator devices market was valued at USD 1.06 billion in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030. The demand for sacral nerve stimulator devices is primarily being boosted by the increasing figures for urinary retention, urgency frequency, fecal incontinence, and others. Further, the rising adoption of advanced and innovative technologies, the rising demand for minimally invasive treatment approaches, and the increasing product launches and approval among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

Sacral Nerve Stimulator Devices Market Dynamics:

The sacral nerve stimulator devices market is witnessing a positive growth in product demand due to the increasing cases of overactive bladder (OAB), urine & fecal incontinence, prostate cancer, and others. These diseases may disturb the normal lifestyle of a person owing to incontinence of urine and stool. Thus, a sacral nerve stimulator can greatly reduce or eliminate bladder and bowel control problems. For instance, according to American Society of Clinical Oncology 2022, it was estimated that in 2022 nearly 268,490 men in the United States were diagnosed with prostate cancer. As per the same source, it was estimated that approximately 1,414,259 men were diagnosed with prostate cancer worldwide in 2020. Prostate cancer is the most common cancer among men. Prostate cancer causes complications like urinary retention and urges incontinence which makes a person uncomfortable. Urinary retention or urge incontinence can be controlled with the help of a sacral nerve stimulator that senses the urgency of urination and send the signal to the brain. Thus, the increasing cases of prostate cancer may increase the demand for sacral nerve stimulators in the market.

Further, voiding dysfunction, urinary incontinence, fecal incontinence, and other diseases are very common in the older population. People more than 60 years are at a higher risk of developing the afore-said diseases as aging is associated with the increasing prevalence of psychosocial factors which affect the loosening of muscles. As per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world’s population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally. Thus, the increasing geriatric population will be at high risk of urinary incontinence and bladder dysfunction which can be controlled by using a sacral nerve stimulator as sacral nerve stimulator can sense the bladder and send a signal to the brain for urination on time. Thus, the increasing geriatric population may increase the demand for sacral nerve stimulators, thereby propelling the overall market growth.

Therefore, the above-mentioned factors are contributing to the growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

However, complications related to implantable devices, and others may restrict the sacral nerve stimulator devices market growth.

The sacral nerve stimulator market was negatively impacted during the period of COVID-19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits, the suspension of non-emergency hospital visits, and the cancellation of surgical procedures. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatient visits and surgeries for the treatment of various chronic ailments, thereby bringing the demand for products on track in the sacral nerve stimulator market.

Sacral Nerve Stimulator Devices Market Segment Analysis:

Sacral nerve stimulator devices by Product (Implantable Nerve Stimulator and External Nerve Stimulator), Application (Overactive Bladder (OAB), Urinary or Bowel Urge Incontinence, Chronic Fecal Incontinence, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the sacral nerve stimulator devices market, the implantable nerve stimulator category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.

For instance, the advantages of implantable sacral nerve stimulators over other products include quicker signal response, less discomfort, minimal invasion, and shorter operating times.

The increasing prevalence of OAB, urine & fecal incontinence, and others may also increase the demand for implantable nerve stimulators.

OAB may affect relationships with friends and family. It can disrupt a person’s sleep & sex life and can leave anyone tired and depressed. OAB can lead to urge incontinence, urinating frequent, nocturia, and others. An implantable nerve stimulator can be used to sense quicker urine urgency and can send a signal of the urgency to the brain which may aid in curing the symptoms of urinary incontinence. Thus, the increasing demand for sacral nerve stimulators for the treatment of OAB may lead to an increased demand for implantable nerve stimulator devices.

Furthermore, the increasing awareness regarding sacral nerve stimulators, product launches, and approvals are also a factor for the implantable sacral nerve stimulator market growth. For instance, in 2022, the Axonics F15 device was cleared by the FDA, allowing it to be implanted for upward of 16 years to block the abnormal nerve signals linked to overactive bladder and fecal incontinence.

Therefore, the advantages offered by implantable sacral nerve stimulators are predicted to contribute to the increasing demand for this product thereby driving the growth of the overall sacral nerve stimulator devices market during the forecast period.

North America is expected to dominate the overall Sacral Nerve Stimulator Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sacral nerve stimulator devices market in the year 2023. Factors such as the growing prevalence of urine & fecal incontinence and the increasing cases of OAB are driving the North America sacral nerve stimulator devices market. Further, the increasing geriatric population, the high disposable income, the sophisticated healthcare infrastructure, the regulatory approval for new devices, and the high awareness about the devices also helped the market growth in this region.

Further, people who have urinary retention may have complications, including urinary tract infection (UTI), bladder damage, and kidney damage. According to the Urology Care Foundation 2020, UTIs are very common in the US. In premenopausal women, an annual estimated incidence of UTI is 0.5 - 0.7 per person reported in the US, yearly.

Further, various studies have stated that sacral neuromodulator (SNM) has a positive therapeutic effect on the lower urinary tract and has shown to be an effective treatment for UTI. The urinary tract infection may cause urge incontinence and these patients may require sacral nerve stimulators.

Moreover, the device can also be discontinued at any time without any permanent damage to the nerve. Thus, the increasing number of cases of UTI may increase the number of urinary incontinence cases, ultimately increasing the demand for sacral nerve stimulators, thereby increasing the overall market in the region.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in February 2022 Medtronic plc, a global leader in healthcare technology, received approval from the US Food and Drug Administration (FDA) for InterStim X™, the next generation of the InterStim™ portfolio's recharge-free neurostimulation device, which offers more than 10 years of battery life without the need to recharge, providing patients with more freedom and less maintenance. Thus, such strategic steps help to increase the demand for sacral nerve stimulator devices, thereby driving the North American sacral nerve stimulator devices market forward during the forecast period.

Sacral Nerve Stimulator Devices Market Key Players:

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

Recent Developmental Activities in the Sacral Nerve Stimulator Devices Market:

• In February 2023, the US FDA approved Axonics Inc’s 4th-generation rechargeable neurostimulator for the treatment of fecal incontinence and overactive bladder.
• In August 2021, in the US Finetech-Brindley, a bladder control system was launched as an active implantable medical device and is intended for restoration of bladder function after a complete spinal cord injury. Later the Finetech Brindley bladder control system is named academically as a sacral anterior root stimulator. It is an external, wireless device used to control the implant and its function.

Key Takeaways from the Sacral Nerve Stimulator Devices Market Report Study

Market size analysis for current sacral nerve stimulator devices market size (2023), and market forecast for 6 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sacral nerve stimulator devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global sacral nerve stimulator devices market.

Various opportunities available for the other competitor in the sacral nerve stimulator devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sacral nerve stimulator devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sacral nerve stimulator devices market growth in the coming future?

Target Audience who can be benefited from this Sacral Nerve Stimulator Devices Market Report Study

Sacral nerve stimulator devices products providers

Research organizations and consulting companies

Sacral nerve stimulator device s-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sacral nerve stimulator devices

Various End-users who want to know more about the sacral nerve stimulator devices market and the latest technological developments in the sacral nerve stimulator devices market.

Frequently Asked Questions for the Sacral Nerve Stimulator Devices Market:

1. What are sacral nerve stimulator devices?

The sacral nerve stimulator delivers gentle electrical impulses through a probe (a thin wire) that is placed near the sacral nerve thereby stimulating the bowel and bladder muscles to work normally.

2. What is the market for global sacral nerve stimulator devices?

The global sacral nerve stimulator devices market was valued at USD 1.06 billion in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030.

3. What are the drivers for global sacral nerve stimulator devices market?

The demand for sacral nerve stimulator devices is primarily being heightened by the increasing prevalence of overactive bladder, increasing cases of urge incontinence & fecal incontinence, the rising prevalence of prostate cancer, and others. In addition, the advancement in sacral nerve stimulator devices, and the increasing device launches and approvals among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sacral nerve stimulator devices market?

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

5. Which region has the highest share in the sacral nerve stimulator devices market?

North America is expected to dominate the overall sacral nerve stimulator devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of overactive bladder conditions (OAB) and urge incontinence, the increasing geriatric population, the growing demand for non-invasive treatment, and other factors aid in the growth of the sacral nerve stimulator market in North America. Furthermore, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices also helped the market growth in this region.


This product will be delivered within 2 business days.